AI-driven diabetic retinopathy screening involves the use of deep learning technology and CNN algorithms for analysis of the retinal fundus images to diagnose diabetic retinopathy, one of the top reasons for preventable blindness in people who have d... Explore Report »
Healthcare
Research Reports in Healthcare
Showing 10 results in Healthcare
Radiotheranostics refers to precision oncology technology that employs diagnostic imaging and radiotherapy based on the same or highly similar molecular targets. First, doctors perform diagnostic imaging in order to detect tumors with the presence of... Explore Report »
Viral vector and plasmid DNA manufacturing refers to the production of biological products used in gene therapy, cell therapy, and vaccines. Such biological products facilitate the delivery of genetic material into the target cells and assist in adva... Explore Report »
Strategic investments by CDMOs and pharma giants are fueling large-scale biomanufacturing capacity growth throughout the U.S. Increasing healthcare spending and insurance coverage for biologic and specialty medicines is driving demand for outsourced ... Explore Report »
Increasing disease burden and growing hospitalizations are generating demand for physiological saline. Growing geriatric population is driving the market growth, as elderly patients need intravenous fluids repeatedly for treatment and hydration purpo... Explore Report »
Growing investments in life sciences infrastructure and biomanufacturing facilities are fueling market growth in developed and emerging economies. Increasing need for biopharmaceuticals and vaccines continues to drive widespread adoption of high-qual... Explore Report »
Rising prevalence of chronic diseases is fueling demand for biomarker-based immunoassays. Aging population is increasing the need for disease monitoring and biomarker testing. High costs of immunoassay kits and complexity of assay development are con... Explore Report »
Innovations in biologics and gene therapies are creating new treatments for complex conditions, offering targeted and potentially curative options in areas like oncology and rare diseases. Aging population and rising chronic disease rates are driving... Explore Report »
Growing ethical concerns and legislative changes surrounding animal testing are a key driver. This technology provides a more accurate and human-relevant platform for assessing drug efficacy and toxicity, moving away from animal models that often fai... Explore Report »
The rising number of clinical trials for gene and cell therapies drives the U.S. plasmid DNA manufacturing market growth. These advanced treatments are heavily dependent on a large and consistent supply of high-quality plasmid DNA to support their de... Explore Report »
